SFARI has recently implemented a number of changes to SFARI Gene, including modification of the gene scoring, copy number variant, animal models and protein interaction modules. Curation of the human gene module will continue as before.

SFARI announces that it has selected five fellows in response to the 2019 Bridge to Independence Award request for applications.

Funds donated by SFARI to Gordon Research Conferences will now be allocated to support attendance of eligible early-career (pre-tenure) women, early-career trainees from historically underrepresented groups and scientists from the following ethnic and racial groups: Hispanic or Latino, American Indian or Alaska Native, Black or African American, Native Hawaiian or Other Pacific Islander.

SFARI is now curating a set of zebrafish lines to study autism spectrum disorder. This includes mutant lines for 12 ASD risk genes, four of which are currently available to researchers and eight that will be available later this year.

SFARI director Louis Reichardt will leave SFARI this coming October.

SFARI has awarded four grants in response to the 2019 Novel Outcome Measures in Autism Spectrum Disorder (ASD) request for applications. These grants will support the development and validation of outcome measures aimed at assessing core symptoms of ASD and behavioral changes following treatment.

A uniform call-set of joint variant calls, including single-nucleotide variants and indels, for 9,209 samples with whole-genome sequencing data from the Simons Simplex Collection is now available.

Six current and past SFARI Investigators were among the 100 newly elected members of the National Academy of Medicine.